Open AccessThe Role of American Thyroid Association Pediatric Thyroid Cancer Risk Stratification and BRAFV600E Mutation in Predicting the Response to Treatment in Papillary Thyroid Cancer Patients ≤18 Years Old
Author(s) -
Yasemin Giles Şenyürek,
Yalın İşcan,
İsmail Cem Sormaz,
Şükran Poyrazoğlu,
Fatih Tunca
Publication year - 2022
Publication title -
jcrpe
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.566
H-Index - 35
eISSN - 1308-5735
pISSN - 1308-5727
DOI - 10.4274/jcrpe.galenos.2022.2021-10-4
Subject(s) - medicine , thyroid cancer , risk stratification , papillary thyroid cancer , thyroid , oncology , cancer , gastroenterology
This study aimed to evaluate the role of risk stratification by the American Thyroid Association (ATA) pediatric thyroid cancer risk levels and BRAF V600E mutation to predict the response to treatment in papillary thyroid cancer (PTC) patients ≤18 years old.